Nov 5 (Reuters) - Molecular diagnostics firm
BillionToOne raised $273.1 million in its U.S. initial public
offering on Wednesday, pricing its shares above its marketed
range at $60 per share.
(Reporting by Bipasha Dey in Bengaluru; Editing by Mrigank
Dhaniwala)